1. A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel-arm
Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablets
Regimens in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease
(TEMPO3/4)
2. HALT Progression of Polycystic Kidney Disease (HALT PKD)
3. Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
4. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP
II) Poster presentation at American Society of Nephrology (ASN) annual meeting:
" Nephrogenic Systemic Fibrosis with Gadodiamide Injection (Omniscan): The
Emory Experience” San Francisco, CA – 11/2007; Poster presentation
at National Kidney Foundation (NKF) Spring Clinical Meeting:
“ Factors Associated with Microalbuminuria in Resistant Hypertensive type
2 Diabetics Undergoing Screening for Primary Hyperaldosteronism “ Orlando,
FL – 04/2007
I degree Diploma award in Experimental Biology students State educational conference:
“ DNA-polymerase activity in rat brain Cell nucleuses and isolated nuclear
matrix” Tbilisi, Georgia (Europe)